BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14687894)

  • 1. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes.
    Fujinami A; Obayashi H; Ohta K; Ichimura T; Nishimura M; Matsui H; Kawahara Y; Yamazaki M; Ogata M; Hasegawa G; Nakamura N; Yoshikawa T; Nakano K; Ohta M
    Clin Chim Acta; 2004 Jan; 339(1-2):57-63. PubMed ID: 14687894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus.
    Youn BS; Yu KY; Park HJ; Lee NS; Min SS; Youn MY; Cho YM; Park YJ; Kim SY; Lee HK; Park KS
    J Clin Endocrinol Metab; 2004 Jan; 89(1):150-6. PubMed ID: 14715842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus.
    Schäffler A; Büchler C; Müller-Ladner U; Herfarth H; Ehling A; Paul G; Schölmerich J; Zietz B
    Horm Metab Res; 2004 Oct; 36(10):702-7. PubMed ID: 15523596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reduced resistin levels in patients with type 2 diabetes mellitus].
    Yang J; Li M; Wu CY; Wang H; Xu QS; Deng JY
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1471-4. PubMed ID: 14521723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance.
    Pfützner A; Langenfeld M; Kunt T; Löbig M; Forst T
    Clin Lab; 2003; 49(11-12):571-6. PubMed ID: 14651328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low resistin levels in adipose tissues and serum in high-fat fed mice and genetically obese mice: development of an ELISA system for quantification of resistin.
    Maebuchi M; Machidori M; Urade R; Ogawa T; Moriyama T
    Arch Biochem Biophys; 2003 Aug; 416(2):164-70. PubMed ID: 12893293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity.
    Hasegawa G; Ohta M; Ichida Y; Obayashi H; Shigeta M; Yamasaki M; Fukui M; Yoshikawa T; Nakamura N
    Acta Diabetol; 2005 Jun; 42(2):104-9. PubMed ID: 15944845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects.
    Heilbronn LK; Rood J; Janderova L; Albu JB; Kelley DE; Ravussin E; Smith SR
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1844-8. PubMed ID: 15070954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum resistin (FIZZ3) protein is increased in obese humans.
    Degawa-Yamauchi M; Bovenkerk JE; Juliar BE; Watson W; Kerr K; Jones R; Zhu Q; Considine RV
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5452-5. PubMed ID: 14602788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects.
    Lee JH; Chan JL; Yiannakouris N; Kontogianni M; Estrada E; Seip R; Orlova C; Mantzoros CS
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4848-56. PubMed ID: 14557464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum resistin is not associated with obesity or insulin resistance in humans.
    Iqbal N; Seshadri P; Stern L; Loh J; Kundu S; Jafar T; Samaha FF
    Eur Rev Med Pharmacol Sci; 2005; 9(3):161-5. PubMed ID: 16080635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistin concentrations in murine adipose tissue and serum measured by a new enzyme immunoassay.
    Fujinami A; Ohta K; Matsui H; Kitada N; Kitaura Y; Kawahara Y; Obayashi H; Kuno S; Nakamura N; Ohta M
    Obesity (Silver Spring); 2006 Feb; 14(2):199-205. PubMed ID: 16571844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus.
    Al-Harithy RN; Al-Ghamdi S
    Ann Saudi Med; 2005; 25(4):283-7. PubMed ID: 16212119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes.
    McTernan PG; Fisher FM; Valsamakis G; Chetty R; Harte A; McTernan CL; Clark PM; Smith SA; Barnett AH; Kumar S
    J Clin Endocrinol Metab; 2003 Dec; 88(12):6098-106. PubMed ID: 14671216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes.
    Lu HL; Wang HW; Wen Y; Zhang MX; Lin HH
    World J Gastroenterol; 2006 Mar; 12(11):1747-51. PubMed ID: 16586545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls.
    Fehmann HC; Heyn J
    Horm Metab Res; 2002; 34(11-12):671-3. PubMed ID: 12660880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance.
    Gerber M; Boettner A; Seidel B; Lammert A; Bär J; Schuster E; Thiery J; Kiess W; Kratzsch J
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4503-9. PubMed ID: 15928242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters.
    Chen CC; Li TC; Li CI; Liu CS; Wang HJ; Lin CC
    Metabolism; 2005 Apr; 54(4):471-5. PubMed ID: 15798953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians.
    Vozarova de Courten B; Degawa-Yamauchi M; Considine RV; Tataranni PA
    Diabetes; 2004 May; 53(5):1279-84. PubMed ID: 15111497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia.
    Lee JH; Bullen JW; Stoyneva VL; Mantzoros CS
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E625-32. PubMed ID: 15522996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.